Last reviewed · How we verify
testosterone anastrozole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
testosterone anastrozole (testosterone anastrozole) — Havah Therapeutics Pty Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| testosterone anastrozole TARGET | testosterone anastrozole | Havah Therapeutics Pty Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- testosterone anastrozole CI watch — RSS
- testosterone anastrozole CI watch — Atom
- testosterone anastrozole CI watch — JSON
- testosterone anastrozole alone — RSS
Cite this brief
Drug Landscape (2026). testosterone anastrozole — Competitive Intelligence Brief. https://druglandscape.com/ci/testosterone-anastrozole. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab